Medically Unexplained Symptoms
12
2
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (12)
Mapping the Healthcare Pathway to Multidisciplinary Assessment of 12-25 Year Olds With Somatic Symptom Disorder
Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study
Exposure Therapy vs. Standardized Education for Distress Related to Somatic Symptoms
ISTDP for Patients with Treatment Resistance PPS
Stress and Musculoskeletal Health in Employees
VivAer: A Correlation Between Symptom Scores and Objective Findings
Parent Training for Youth With Chronic Symptoms
Welfare Benefits in Functional Somatic Disorders
Psychological Risk Factors for Functional Somatic Disorders
Sense of Coherence and Empowerment at Patients With MUPS
Hypnosis in Internal Medecine
Psychosomatic Therapy, Feasibility and Cost Analysis